CCS
ELAN icon

Concentric Capital Strategies’s Elanco Animal Health ELAN Stock Holding History

Concentric Capital Strategies’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-186,029
Closed -$3.03M – 317
2024
Q1 		$3.03M Buy
186,029
+32,063
+21% +$501K 0.17% 140
2023
Q4 		$2.29M Buy
+153,966
New +$1.74M 0.26% 97

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Concentric Capital Strategies's ELAN Position: Q2 2024 in Review

Concentric Capital Strategies sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 186,029 shares — an estimated $3.03M sold.

Concentric Capital Strategies first reported a position in ELAN in Q4 2023 and held it in 2 quarters. The position peaked at $3.03M in Q1 2024. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

  • Concentric Capital Strategies reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
  • Concentric Capital Strategies sold 186,029 Elanco Animal Health shares in Q2 2024, an estimated $3.03M.
  • Concentric Capital Strategies first reported a position in Elanco Animal Health in Q4 2023 and held it in 2 quarters.
  • Concentric Capital Strategies's Elanco Animal Health position peaked at $3.03M in Q1 2024.
  • 402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Concentric Capital Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.